Why climate change will have a major impact on the future of healthcare across the world
Climate change will be one of the key factors in global healthcare trends over the next 50 years as people are forced from their homes and deal with extreme heat, says new study co-authored at Cambridge Judge Business School. Climate…
Heart surgery delays will cost lives, warns research
Study co-authored by Professors Feryal Erhun and Houyuan Jiang of Cambridge Judge Business School finds that the pandemic has delayed lifesaving treatment for thousands of people with severe aortic stenosis. Urgent action is needed to clear the backlog of people…
Mirage News: Heart surgery delays will cost lives, warns research
Urgent action is needed to clear the backlog of people with a common heart condition who are waiting for lifesaving treatment, warns research co-authored by Cambridge Judge Business School and published in the journal BMJ Open. The study, conducted by…
Ukraine: medics in conflict zones
Mark de Rond, Professor of Organisational Ethnography at Cambridge Judge Business School, embedded with military surgeons in Afghanistan for six weeks. He describes the challenges faced by doctors and nurses in conflict zones like Ukraine. Quite aside from the deadly…
Pharma shift
The pharmaceutical industry's focus on procedures and dealmaking could change significantly in this uncertain period, five Cambridge Executive MBA graduates say in a webinar for the What's Next? How to Survive and Thrive in a Post COVID-19 World series. Here's…
Investing in Cambridge drug discovery
PharmEnable raises £1.8 million for drug discovery expansion. PharmEnable, a venture supported by the Accelerate Cambridge programme at the Entrepreneurship Centre of Cambridge Judge Business School, said it has secured £1.8 million in a seed financing round led by Cambridge…
Biotech vs big pharma
Most approved "priority" medicines are developed by biotech rather than large pharmaceutical firms, says a two-decade study at the University of Cambridge Judge Business School. Biotech companies created 40 per cent more US Food & Drug Administration-approved "priority" drugs than…
Manhattan Project?
A "multiple-shots-on-goal" approach is needed to find coronavirus drugs, Cambridge Judge academics say in California Management Review. A many-shots-on-goal approach - not command and control - will most effectively develop vaccines and treatments for COVID-19 (coronavirus), Cambridge Judge Business School academics say in a new California Management Review article. Professor Christoph Loch While some have suggested…
Drug trials
An Executive MBA alumnus, Dr Rav Seeruthun, heads a Roche team that has developed a drug being tested to fight COVID-19. Dr Rav Seeruthun (EMBA 2013) of Cambridge Judge Business School, is heading a team at the Roche UK Medical Directorate that has developed…
AI and health
The Entrepreneurship Centre at Cambridge Judge supports new programme that uses artificial intelligence to tackle major NHS challenges. The Entrepreneurship Centre at Cambridge Judge Business School and the Eastern Academic Health Science Network (Eastern AHSN) are sponsoring a new programme…
